Screening urged for hepatitis C but drug costs are prohibitive
نویسندگان
چکیده
منابع مشابه
Sustained drug use changes following hepatitis C screening
Bruneau, J 1,2 , Zang, G 1 , Abrahamowicz, M 3 , Jutras-Aswad, D 1,4 , Daniel, M 5 , Roy, E 6,7 . 1 Research Center, Centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada. 2 Department of Family Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada. 3 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montr...
متن کاملUniversal antenatal screening for hepatitis C.
The aims of this study were to pilot universal antenatal HCV screening and to determine the true seroprevalence of HCV infection in an unselected antenatal population. A risk assessment questionnaire for HCV infection was applied to all women booking for antenatal care over a 1-year period. In addition the prevalence of anti-HCV antibody positive serology in this population was determined. Over...
متن کاملCosts and benefits of preemployment drug screening.
OBJECTIVE This study provides a cost-benefit analysis of preemployment drug screening and evaluates the sensitivity of this analysis to variation in its underlying assumptions. DESIGN Cost-benefit analysis, based on a cohort analytic study previously reported. SETTING Employees of the US Postal Service in Boston, Mass. PARTICIPANTS Estimates of costs and benefit are based on a cohort of 2...
متن کاملNew drug candidates for hepatitis C treatment
The more advantageous hepatitis C virus (HCV) inhibitors (most of them incorporating polysubstituted prolines or pyrrolidines) are detailed in this paper. The improvement of current treatments by combination of antiviral drugs is the driving force of this race to reduce the fast proliferation of this virus. The enhancement of efficiency in short periods of treatment is crucial in the economical...
متن کاملReal-life costs of hepatitis C treatment.
BACKGROUND Hepatitis C virus infection is a serious health threat in today's society. Improved identification strategies have increased the number of patients undergoing the expensive treatment with ribavirin and peg-interferon, inducing a substantial economic burden. METHODS In a retrospective cohort study in three treatment centres in the Netherlands, files of patients treated between 2001 ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2014
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.109-4727